Walleye Capital’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-26,523
Closed -$869K 3769
2022
Q2
$869K Buy
+26,523
New +$838K 0.02% 716
2020
Q4
Sell
-10,486
Closed -$180K 1184
2020
Q3
$180K Buy
+10,486
New +$198K 0.02% 636
2019
Q3
Sell
-1,634
Closed -$42K 2379
2019
Q2
$42K Buy
+1,634
New +$41.6K ﹤0.01% 1415

Other funds holding NTUS

Walleye Capital's NTUS Position: Q3 2022 in Review

Walleye Capital sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 26,523 shares — an estimated $869K sold.

Walleye Capital first reported a position in NTUS in Q2 2019 and held it in 3 quarters. The position peaked at $869K in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Walleye Capital reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Walleye Capital sold 26,523 Natus Medical Inc shares in Q3 2022, an estimated $869K.
  • Walleye Capital first reported a position in Natus Medical Inc in Q2 2019 and held it in 3 quarters.
  • Walleye Capital's Natus Medical Inc position peaked at $869K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Walleye Capital's 13F filing for Q3 2022, filed 14 Nov 2022.